The Pep Talk: PT-141 Bremelanotide Explored

Published: July 12, 2019, 5 a.m.

b'SHR # 2374 :: The Pep Talk: PT-141 Bremelanotide Explored : Dr. Elizabeth Yurth - In light of Vyleesi being approved by the FDA for Hypoactive Sexual Desire Disorder HSDD in pre-menopausal women its time to revisit the science behind PT-141 Bremelanotide. This peptide is the only legitimate aphrodisiac that activates libido and arousal in women. It also works in men in higher doses than those used in women. We will discuss all aspects of use of this peptide and any unwanted effects.'